Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016361038> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2016361038 endingPage "556" @default.
- W2016361038 startingPage "552" @default.
- W2016361038 abstract "Abstract. Current drugs used for hyperprolactinemia may have severe side effects. Effects and side effects of a new propylergoline derivate (CQP 201-403 SANDOZ®) have been evaluated. Twenty-four otherwise healthy women (21–44 years) with hyperprolactinemia (35–318 μg/l) without extrasellar extension of pituitary adenomas took part in a randomized, doubleblind study. Fasting prolactin levels measured on day 7 was significantly decreased when compared with day 1 ( P < 0.05) in all CQP groups, to 78% with 0.005 mg daily, to 40% with 0.015 mg daily, and to 27% with 0.025 mg CQP per day for one week. The levels in the control group did not change (96%). The area under the curve of the prolactin day curve (1–8 h after drug administration) decreased significantly ( P < 0.05) at all doses when day 7 was compared with day 1, to 77% with 0.005 mg, to 51% with 0.015 mg, and to 37% with 0.025 mg CQP. No change was seen in the control group (96%). Four patients (one on 0.005 mg, one on 0.015 mg, and two on 0.025 mg) experienced orthostatic hypotension while standing blood pressure was to be measured on the first day of treatment, and they had to lie down. CQP 201-403 lowers prolactin levels in hyperprolactinemic women at all doses employed. The effect was seen after the first dose of treatment, and lasted for at least 24 h. The adverse reactions are few and tolerable, and might be less than with current bromocriptine therapy." @default.
- W2016361038 created "2016-06-24" @default.
- W2016361038 creator A5006710579 @default.
- W2016361038 creator A5011628315 @default.
- W2016361038 creator A5020174799 @default.
- W2016361038 creator A5022153050 @default.
- W2016361038 creator A5040869753 @default.
- W2016361038 creator A5048338871 @default.
- W2016361038 creator A5071721348 @default.
- W2016361038 date "1988-04-01" @default.
- W2016361038 modified "2023-09-28" @default.
- W2016361038 title "CQP 201-403, a new dopamine agonist in the treatment of hyperprolactinemia" @default.
- W2016361038 doi "https://doi.org/10.1530/acta.0.1170552" @default.
- W2016361038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3291529" @default.
- W2016361038 hasPublicationYear "1988" @default.
- W2016361038 type Work @default.
- W2016361038 sameAs 2016361038 @default.
- W2016361038 citedByCount "3" @default.
- W2016361038 crossrefType "journal-article" @default.
- W2016361038 hasAuthorship W2016361038A5006710579 @default.
- W2016361038 hasAuthorship W2016361038A5011628315 @default.
- W2016361038 hasAuthorship W2016361038A5020174799 @default.
- W2016361038 hasAuthorship W2016361038A5022153050 @default.
- W2016361038 hasAuthorship W2016361038A5040869753 @default.
- W2016361038 hasAuthorship W2016361038A5048338871 @default.
- W2016361038 hasAuthorship W2016361038A5071721348 @default.
- W2016361038 hasConcept C126322002 @default.
- W2016361038 hasConcept C134018914 @default.
- W2016361038 hasConcept C170493617 @default.
- W2016361038 hasConcept C197934379 @default.
- W2016361038 hasConcept C2778938600 @default.
- W2016361038 hasConcept C2779064019 @default.
- W2016361038 hasConcept C513476851 @default.
- W2016361038 hasConcept C71315377 @default.
- W2016361038 hasConcept C71924100 @default.
- W2016361038 hasConcept C73787029 @default.
- W2016361038 hasConcept C76318530 @default.
- W2016361038 hasConcept C84393581 @default.
- W2016361038 hasConceptScore W2016361038C126322002 @default.
- W2016361038 hasConceptScore W2016361038C134018914 @default.
- W2016361038 hasConceptScore W2016361038C170493617 @default.
- W2016361038 hasConceptScore W2016361038C197934379 @default.
- W2016361038 hasConceptScore W2016361038C2778938600 @default.
- W2016361038 hasConceptScore W2016361038C2779064019 @default.
- W2016361038 hasConceptScore W2016361038C513476851 @default.
- W2016361038 hasConceptScore W2016361038C71315377 @default.
- W2016361038 hasConceptScore W2016361038C71924100 @default.
- W2016361038 hasConceptScore W2016361038C73787029 @default.
- W2016361038 hasConceptScore W2016361038C76318530 @default.
- W2016361038 hasConceptScore W2016361038C84393581 @default.
- W2016361038 hasIssue "4" @default.
- W2016361038 hasLocation W20163610381 @default.
- W2016361038 hasLocation W20163610382 @default.
- W2016361038 hasOpenAccess W2016361038 @default.
- W2016361038 hasPrimaryLocation W20163610381 @default.
- W2016361038 hasRelatedWork W1969139594 @default.
- W2016361038 hasRelatedWork W2006797593 @default.
- W2016361038 hasRelatedWork W2017638447 @default.
- W2016361038 hasRelatedWork W2034255477 @default.
- W2016361038 hasRelatedWork W2038081958 @default.
- W2016361038 hasRelatedWork W2058205365 @default.
- W2016361038 hasRelatedWork W2062579683 @default.
- W2016361038 hasRelatedWork W2120946541 @default.
- W2016361038 hasRelatedWork W2123442016 @default.
- W2016361038 hasRelatedWork W2163744984 @default.
- W2016361038 hasVolume "117" @default.
- W2016361038 isParatext "false" @default.
- W2016361038 isRetracted "false" @default.
- W2016361038 magId "2016361038" @default.
- W2016361038 workType "article" @default.